4//SEC Filing
Kewalramani Reshma 4
Accession 0000875320-25-000131
CIK 0000875320other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:43 PM ET
Size
4.5 KB
Accession
0000875320-25-000131
Insider Transaction Report
Form 4
Kewalramani Reshma
DirectorCEO & President
Transactions
- Tax Payment
Common Stock
2025-02-26$479.61/sh−14,079$6,752,429→ 105,915 total
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001735944
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:43 PM ET
- Size
- 4.5 KB